Clinical application of thioredoxin reductase as a novel biomarker in liver cancer
Abstract Hepatic cancer is often amenable to surgery, including percutaneous ablation, trans-arterial chemoembolization. However, in metastatic cases, surgery is often not an effective option. Chemotherapy as a conventional clinical method for treatment of malignant diseases may be useful in such ca...
Enregistré dans:
Auteurs principaux: | Xuping Wu, Qi Wang, Yousheng Lu, Jinye Zhang, Hanwei Yin, Yongxiang Yi |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/ea2342db5ee242668d9b3e5263a5e4c3 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Chlorophyllin Inhibits Mammalian Thioredoxin Reductase 1 and Triggers Cancer Cell Death
par: Shibo Sun, et autres
Publié: (2021) -
Cell death by SecTRAPs: thioredoxin reductase as a prooxidant killer of cells.
par: Karin Anestål, et autres
Publié: (2008) -
Polymorphisms in thioredoxin reductase and selenoprotein K genes and selenium status modulate risk of prostate cancer.
par: Catherine Méplan, et autres
Publié: (2012) -
Sulforaphane-induced transcription of thioredoxin reductase in lens: possible significance against cataract formation
par: Varma SD, et autres
Publié: (2013) -
Yeast thioredoxin reductase Trr1p controls TORC1-regulated processes
par: Cecilia Picazo, et autres
Publié: (2018)